Purchase Order 15F06726P0000246
- Not listed
- Valneva USA, Inc., doing business as Intercell USA Inc., has been awarded a $17,422.20 firm fixed price delivery order against its Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) by the Department of Health and Human Services Office of the Assistant Secretary for Administration. The delivery order is for IXIARO vaccine for stock and requires delivery to a location in Potomac, Maryland by August 31, 2023. Valneva USA, a foreign-owned, for-profit organization, will fulfill...
- This contract award is for vaccines to be delivered by Valneva USA, Inc. to the Federal Bureau of Investigation. The vaccines included but are not limited to hepatitis A and B, measles-mumps-rubella, tetanus-diphtheria, tetanus-diphtheria-pertussis, meningitis, rabies, polio, typhoid injectable and oral, and yellow fever. Valneva USA, Inc. will deliver these vaccines under a $38,850.60 firm fixed price contract with no set-aside designation to the FBI headquarters in Hyattsville, Maryland by...
- This is a federal contract award to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, by the U.S. Department of Justice. The award, valued at $62,179.00, is for the delivery of various vaccines, including but not limited to hepatitis A, hepatitis B, measles-mumps-rubella (MMR), tetanus-diphtheria (Td), and meningitis, among others. This is a Blanket Purchase Agreement (BPA) call order, with a firm fixed price pricing type and an ultimate completion date of...
- This federal contract award, valued at $10,638,400.00, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contract is a firm fixed price delivery order with a period of performance through September 30, 2024. Valneva USA, a subsidiary of the France-based Valneva SE, is the prime contractor and holds several other significant...
- The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a firm fixed price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned for-profit organization, to provide the IXIARO vaccine. The contract has a potential value of $112,564.50 and a completion date of March 22, 2024. This delivery order is part of Valneva USA's GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). Valneva USA has...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned for-profit organization, to provide the IXIARO vaccine. The $111,630.00 contract is not associated with a set-aside program and is being fulfilled at Valneva's facility in Potomac, Maryland. Valneva USA has received multiple federal vaccine contracts, primarily for the Department of Defense, Department of...
- Valneva USA, Inc. was awarded a $103,952.46 firm fixed price delivery order by the Department of Health and Human Services Office of the Assistant Secretary for Administration for IXIARO vaccine stock. This delivery order was issued against Valneva USA's Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), which has no set-aside designation. Valneva USA will deliver the IXIARO vaccine to the stated place of performance in Potomac, Maryland by February 2023. As the prime...
- Valneva USA, Inc. was awarded a $115,748.83 firm fixed price delivery order by the Department of Health and Human Services Office of the Assistant Secretary for Administration for IXIARO vaccine stock. The delivery order was issued against Valneva USA's Pharmaceuticals and Drugs Federal Supply Schedule contract, which provides vaccines to federal agencies to support public health and safety programs. Valneva USA will deliver the IXIARO vaccine to the stated place of performance in Potomac,...
- This federal contract award is for the delivery of the IXIARO vaccine to the U.S. government. The contract, valued at $179,538.25, was awarded to Valneva USA, Inc., a subsidiary of the French specialty vaccine company Valneva SE. The contract is a firm fixed price Delivery Order placed against the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule Contract. This contract does not have a set-aside designation. Valneva USA, Inc. has been a key supplier of vaccines, particularly the...
- Valneva USA, Inc. was awarded a $32,518.08 firm fixed price delivery order from the Department of Health and Human Services Office of the Assistant Secretary for Administration for IXIARO vaccine stock. The award was issued under Valneva USA's Pharmaceuticals and Drugs Federal Supply Schedule contract, which has no set-aside designation. Valneva USA will deliver the vaccine to the stated place of performance in Potomac, Maryland by December 1, 2023. Valneva USA is a subsidiary of Valneva SE, a...
Valneva USA, Inc., doing business as Intercell USA Inc., was awarded a $10,000 firm fixed-price purchase order by the Federal Bureau of Investigation Headquarters Division on February 13, 2026, for medical supplies and vaccines. The contract is scheduled for ultimate completion on March 11, 2027, with performance taking place in Bethesda, Maryland. This award carries no set-aside designation and represents a child contract under Valneva USA's broader federal vaccine supply relationships. Valneva USA is a foreign-owned subsidiary of French-based Valneva SE and serves as a critical vaccine supplier to multiple federal agencies, with particular expertise in the IXIARO Japanese encephalitis vaccine. The company maintains three significant indefinite delivery vehicles totaling over $101 million with the Defense Logistics Agency and Department of Veterans Affairs, which serve as the primary procurement frameworks for federal vaccine distribution supporting military readiness and public health initiatives. This purchase order from the FBI reflects the company's established role as a trusted federal vaccine supplier across civilian and defense agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 2/13/26 |